Biotechs search for buyers as runways end
By Katherine Davis, Axios
Biotech companies with little runway left are trying to position themselves as attractive takeover targets to Big Pharma.
Why it matters: Executives and investors are growing increasingly desperate for exits, industry insiders tell Axios.


